Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-28

Clinical Trial Update: Epi-On Corneal Crosslinking for Keratoconus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Epi-On corneal crosslinking in keratoconus, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epi-On corneal crosslinking

Snippet

Sponsor: Comprehensive EyeCare of Central Ohio | Conditions: Keratoconus, Keratoconus, Unstable | Phase 4 | Status: COMPLETED